Companies market access training capabilities

ISPOR 2018 Companies’ market access training capabilities


Do companies’ market access training capabilities address the needs of today’s complex payer marketplace?

Setting the price and obtaining market access for a new pharmaceutical remains one of the biggest commercial challenges facing manufacturers. As the payer landscape becomes increasingly challenging, demonstrating product value and considering the payer perspective as early as possible in clinical development is increasingly important.

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.